Human medicines European public assessment report (EPAR): Remicade, infliximab, Spondylitis, Ankylosing,Arthritis, Rheumatoid,Psoriasis,Crohn Disease,Arthritis, Psoriatic,Colitis, Ulcerative, Date of authorisation: 13/08/1999, Revision: 54, Status: Authorised